These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2645269)

  • 1. The diagnostic and therapeutic use of monoclonal antibodies in colorectal cancer.
    Kaplan EH
    Hematol Oncol Clin North Am; 1989 Mar; 3(1):125-34. PubMed ID: 2645269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody treatment of colorectal cancer.
    Pullyblank AM; Monson JR
    Br J Surg; 1997 Nov; 84(11):1511-7. PubMed ID: 9393269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
    Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
    Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers in colorectal cancer: diagnostic and therapeutic implications.
    Luk GD; Desai TK; Conteas CN; Moshier JA; Silverman AL
    Gastroenterol Clin North Am; 1988 Dec; 17(4):931-40. PubMed ID: 3068151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in nuclear medicine.
    Keenan AM; Harbert JC; Larson SM
    J Nucl Med; 1985 May; 26(5):531-7. PubMed ID: 2580961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
    Atreya I; Neurath MF
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer.
    Dziki A
    Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784
    [No Abstract]   [Full Text] [Related]  

  • 8. Mean time parameters reveal differences in the pharmacokinetics of indium-111 and iodine-131-labeled B72.3 monoclonal antibody.
    Reilly RM; Thiessen JJ
    J Nucl Med; 1992 Dec; 33(12):2248-50. PubMed ID: 1460524
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
    Welt S; Ritter G; Williams C; Cohen LS; Jungbluth A; Richards EA; Old LJ; Kemeny NE
    Clin Cancer Res; 2003 Apr; 9(4):1347-53. PubMed ID: 12684403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the use of monoclonal antibodies for imaging and therapy.
    Monson JR
    Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.
    Meredith RF; Khazaeli MB; Plott WE; Grizzle WE; Liu T; Schlom J; Russell CD; Wheeler RH; LoBuglio AF
    Clin Cancer Res; 1996 Nov; 2(11):1811-8. PubMed ID: 9816134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of colorectal cancer--overview and perspectives].
    Schimanski CC; Hörner V; Kanzler S; Galle PR; Moehler M
    Z Gastroenterol; 2006 Aug; 44(8):673-81. PubMed ID: 16902899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody.
    Kim JA; Bresler HS; Martin EW; Aldrich W; Heffelfinger M; Triozzi PL
    Cancer; 1999 Jul; 86(1):22-30. PubMed ID: 10391559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant and palliative immunotherapy of colorectal carcinoma].
    Schlimok G
    Praxis (Bern 1994); 1997 Sep; 86(39):1517-9. PubMed ID: 9411672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of radiolabeled human and mouse monoclonal IgM antibodies in murine models.
    Halpern SE; Hagan PL; Chen A; Birdwell CR; Bartholomew RM; Burnett KG; David GS; Poggenburg K; Merchant B; Carlo DJ
    J Nucl Med; 1988 Oct; 29(10):1688-96. PubMed ID: 3171697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for colorectal cancer.
    Midgley RS; Kerr DJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.